News

Winstone’s Voice

Winstone in Seattle, 2005

As has been widely reported, we lost Winstone Zulu, a tireless advocate for TB/HIV (see more info at the TB Alliance and ACTION). I was lucky to have been able to work with Winstone over the years – his greeting was always a hearty: “So when are you coming to Zambia?” I had to laugh because he always seemed to be everywhere all at once, on a tireless global journey to promote TB/HIV awareness.

But he was tired – often exhausted from battling his illness, adverse reactions to therapy, and of course his punishing schedule. And yet, to know him was to marvel at his indomitable spirit, which rarely seemed to miss an opportunity to do some good in the world.

Chief among Winstone’s gifts was the ability to speak with passion about his subject, finding the precise balance between hard facts, personal history, and an inspiring call to action. In 2003, we collaborated on a video to raise awareness about TB/HIV co-infection. The title, “Winstone Zulu is Alive” came from a conversation in which Winstone explained that since the average life expectancy in Zambia was 40 (his figure), he was already living on borrowed time and it was important to remind people that he was still around.

Now that Winstone has passed, the title seems all the more poignant: if you listen to his profoundly moving voice, you realize that his spirit remains very much with us.

John-Michael Maas

Winstone Zulu boarding a ferry in Seattle, 2005

Make a donation to support Winstone’s family

RESULTS has set up an account to make donations to help support Winstone’s family. In order to alert RESULTS that your contribution is for the Winstone Zulu Memorial Fund, you must copy and paste “Winstone Zulu Memorial Fund” into the field that asks, “Who invited you to give to us?” Click here to make a donation.

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...